Leptin, via SOCS-STAT3 transcription activation, activates many downstream signaling pathways, such as MAPK and AKT pathways, resulting in increased angiogenesis, proliferation, decreased cancer cell death, and therapeutic resistance (Cirillo et al., 2008). Here, STAT3 is linked to cancer.